FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1064611000001103: Hyoscine hydrobromide 300microgram tablets 12 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22497101000001114 Hyoscine hydrobromide 300microgram tablets 12 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22497201000001119 Hyoscine hydrobromide 300microgram tablets 12 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hyoscine hydrobromide 300microgram tablets 12 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets 12 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets 12 tablet Is pack of Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets 12 tablet Has active ingredient Scopolamine hydrobromide false Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets 12 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets 12 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets 12 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets 12 tablet Has VMP Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets 12 tablet Has specific active ingredient Scopolamine hydrobromide true Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets 12 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Kwells 300microgram tablets (Dexcel-Pharma Ltd) 12 tablet Is a True Hyoscine hydrobromide 300microgram tablets 12 tablet Inferred relationship Existential restriction modifier
Travel Calm 300microgram tablets (The Boots Company Plc) 12 tablet Is a True Hyoscine hydrobromide 300microgram tablets 12 tablet Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets (J M McGill Ltd) 12 tablet Is a False Hyoscine hydrobromide 300microgram tablets 12 tablet Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets (Colorama Pharmaceuticals Ltd) 12 tablet Is a False Hyoscine hydrobromide 300microgram tablets 12 tablet Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets (Ennogen Healthcare Ltd) 12 tablet Is a False Hyoscine hydrobromide 300microgram tablets 12 tablet Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 300microgram tablets (Niche Pharma Ltd) 12 tablet Is a False Hyoscine hydrobromide 300microgram tablets 12 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start